Table 4.
Lipid Parameters of Dyslipidemia Patients Before Switching Treatment from Brand-Name to Generic Atorvastatin and 6 Months After Stratified by Sex
| Factors | Baseline | 6th Month | Mean Differences | 95% CI | p value |
|---|---|---|---|---|---|
| Sex | |||||
| Female (n = 252) | |||||
| Chol | 178.30 (47.79) | 171.17 (45.08) | −7.12 | −12.88, −1.37 | 0.015 |
| Tg | 140.98 (65.84) | 141.07 (71.80) | 0.08 | −9.36, 9.53 | 0.985 |
| HDL | 53.74 (13.92) | 52.05 (13.05) | −1.68 | −3.07, −0.30 | 0.017 |
| LDL | 111.78 (42.38) | 102.30 (36.98) | −9.48 | −13.89, −5.07 | < 0.001 |
| Male (n = 236) | |||||
| Chol | 170.76 (51.08) | 161.37 (43.03) | −9.38 | −15.24, −3.53 | 0.001 |
| Tg | 147.53 (73.51) | 150.21 (82.91) | 2.67 | −7.31, 12.65 | 0.598 |
| HDL | 49.52 (12.59) | 46.94 (12.56) | −2.58 | −3.90, −1.25 | < 0.001 |
| LDL | 108.27 (47.11) | 99.16 (48.69) | −9.10 | −15.16, −3.03 | 0.003 |
Abbreviations: CI, confidence interval; Chol, cholesterol (mg/dL); Tg, triglyceride (mg/dL); HDL, high-density lipoprotein-cholesterol (mg/dL); LDL, low-density lipoprotein-cholesterol (mg/dL).